Last reviewed · How we verify
NCT03665961: MiPOOP
The Association Between Microbiota, Endotoxaemia and the Host Obesity/ Insulin Resistance (MiPOOP Study)
trial in Central Obesity in 35 participants. Completed in 26 September 2017.
26 September 2017
Quick facts
| Lead sponsor | Changi General Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 35 |
| Start date | 25 October 2016 |
| Primary completion | 26 September 2017 |
| Estimated completion | 26 September 2017 |
| Sites | 1 location across Singapore |
Conditions studied
- Central Obesity — all drugs for Central Obesity →
Sponsor
Changi General Hospital
Who can join
Adults 21 to 75, any sex, with Central Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objectives of this study are to examine the effects of ethnicity, central obesity and dietary components, on the human gut microbiome. The investigators hypothesize that these factors have an influence on the composition of the gut microbiome. Healthy subjects (n=35) provided stool samples for gut microbiome profiling using 16S rRNA sequencing and completed a dietary questionnaire. The serum samples were assayed for a panel of inflammatory cytokines. Their associations with central obesity were examined.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A pilot study to examine the association between human gut microbiota and the host's central obesity.
Koo SH, Chu CW, Khoo JJC, Cheong M, et al · · 2019 · cited 14× · PMID 31832548 · DOI 10.1002/jgh3.12184
Verify or expand the search:
- PubMed search for NCT03665961
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Central Obesity
Currently open trials in the same condition.
- NCT06729203 — Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female · NA · recruiting
- NCT06694012 — Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 · recruiting
- NCT07307898 — Cavitaion vs W-BEMS on Central Obesity · NA · active not recruiting
- NCT05874635 — Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) · NA · active not recruiting
- NCT05121844 — Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform · NA · active not recruiting
Other Changi General Hospital trials
Trials by the same sponsor.
- NCT07297745 — Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) · NA · not yet recruiting
- NCT07205133 — A Randomized Controlled Trial Comparing Whole Body Vibration Therapy With Usual Care and Usual Care to Improve Muscle He · NA · recruiting
- NCT06970717 — Programmable Smart Watch for Remote Pre-habilitation/Rehabilitation Monitoring · NA · not yet recruiting
- NCT06890169 — OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities · NA · recruiting
- NCT06304415 — Elevated Lipoprotein(a) in Hospital Staff · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03665961 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Changi General Hospital
- Last refreshed: 11 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03665961.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing